HI
KYNB

Harbour Investments’s Kyntra Bio KYNB Stock Holding History

Harbour Investments’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51K Hold
200
– – ﹤0.01% 4114
2026
Q1 		$1.36K Buy
+200
New +$1.56K ﹤0.01% 4024
2021
Q4 		– Sell
-16
Closed -$4K – 2981
2021
Q3 		$4K Buy
16
+4
+33% +$1.42K ﹤0.01% 3066
2021
Q2 		$8K Buy
+12
New +$6.91K ﹤0.01% 2838

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Harbour Investments's KYNB Position: Q2 2026 in Review

Harbour Investments held its Kyntra Bio (KYNB) position steady in Q2 2026 at 200 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4114.

Harbour Investments first reported a position in KYNB in Q2 2021 and has held it in 4 quarters since. The position peaked at $8K in Q2 2021. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

  • Harbour Investments held 200 shares of Kyntra Bio worth $1.51K as of Q2 2026.
  • Harbour Investments left its Kyntra Bio share count unchanged in Q2 2026.
  • Kyntra Bio made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4114 holding.
  • Harbour Investments first reported a position in Kyntra Bio in Q2 2021 and has held it in 4 quarters since.
  • Harbour Investments's Kyntra Bio position peaked at $8K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.